Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ajanta Pharma

Ahead of Market: 10 things that will decide stock market action on Tuesday

Indian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 372 points and Nifty lost 110, while analysts advised a buy-on-dips strategy above the key 23,800 support level.

The Economic Times

Prabhudas Lilladher cuts Nifty target to 26,449, lists 16 high conviction stock picks

Amidst global market turmoil from the Iran-US war and El Nino, Prabhudas Lilladher lowered its Nifty 50 target to 26,449. The brokerage anticipates limited further downside but warns of sharp swings due to prolonged uncertainty. Rising geopolitical risks and import dependence are impacting India's economy, potentially curtailing consumption demand.

The Economic Times

Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta

Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.